New product features include JMP integration, BLAST, and AlphaFold to drive faster decision-making and better data-driven insights as labs scale their R&D SAN FRANCISCO — Benchling, the R&D Cloud powering the biotechnology industry, today launched new integrations and features that connect data and analytics tools directly in Benchling with just a few clicks, providing scientists with a […]

Microsoft’s Deputy Chief Technology Officer to be appointed at Annual Shareholders’ Meeting BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the nomination of Lila Tretikov to its Board of Directors. The Board of Directors has proposed the appointment of Tretikov […]

As a leader in data-driven medicine, SOPHiA GENETICS lends its expertise to support White House Cancer Moonshot BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced today at ASCO that it has  joined as a founding member of CancerX, a new public-private partnership […]

DALLAS, TEXAS – Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI. The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham […]

Company to host webinar featuring tips for managing large-scale proteomics data  on UK Biobank Research Analysis Platform   MOUNTAIN VIEW, Calif. —  DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its core platform and Cohort Browser are now optimized for accessing and analyzing large-scale proteomics […]

DALLAS, TEXAS – Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI. The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham […]

Cambridge, UK – Cresset, innovative provider of solutions for CADD, DMTA efficiency and contract research, releases Flare™ V7, a comprehensive drug design platform that integrates the power of ligand and structure-based methods. New features and methods in Flare V7 include significantly enhanced Dynamics and Flare FEP calculations, a new ensemble docking method, enhanced quantitative SAR (QSAR) and Quantum Mechanics (QM) methods, and more tools to troubleshoot Flare […]

The Labbit LIMS platform delivers FAIR-compliant, truly interoperable data from day one, driving operational efficiencies, improved cross-collaboration, and quicker, better-informed decision making Boston, MA – In response to the data management needs of laboratories worldwide, Labbit emerges as a game-changer in the industry. Unlike any other LIMS platforms available, Labbit has been built as FAIR […]

Pioneer in advancing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm selects Genedata Profiler, an industry-leading digital platform for translational and reverse translational research, as the cornerstone of its research and development strategy Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Debiopharm, a […]

The Labbit LIMS platform delivers FAIR-compliant, truly interoperable data from day one, driving operational efficiencies, improved cross-collaboration, and quicker, better-informed decision making Boston, MA – In response to the data management needs of laboratories worldwide, Labbit emerges as a game-changer in the industry. Unlike any other LIMS platforms available, Labbit has been built as FAIR […]